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Postoperative atrial fibrillation (AF) after coronary artery
bypass graft surgery (CABG) is a frequent complication
responsible for high morbidity, a prolonged hospital stay
and significant extra costs (1).
In five controlled trials recently published or presented
orally at meetings (2–6), the incidence of AF was still as
high as 27% to 39%. Progress in operative techniques,
anesthesia and cardioprotection (1,7) do not appear to have
significantly improved the situation. This arrhythmia clas-
sically occurs within 72 h after CABG, and although it
rarely becomes chronic (3.5% in the Canadian survey), it
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may carry serious immediate consequences, including the
increased risk of acute heart failure, thromboembolic events
and anticoagulant-related hemorrhagic complications (1).
The etiology of AF is unclear, but is most probably
multifactorial. Excessive catecholamine production during
the perioperative period plays an undisputed role, along
with pericardial inflammatory reaction, alterations in neu-
rohormonal balance and cellular electrical properties (1). In
any case, a form of electrophysiologic predisposition would
appear to be exacerbated by the acute factors and could be
the real substrate of the arrhythmia (8). Clinical and
electrophysiologic risk factors have also been identified and
generally recognized. Age is the most significant indepen-
dent predictive factor. Hypertension is recognized by some
as a predictive factor and denied by others (1,7). Age and
hypertension directly or indirectly (impairment of left ven-
tricular diastolic function) promote atrial fibrosis and dila-
tion, which in turn may cause the electrophysiologic disor-
ders that participate in the substrate (7). Likewise, the
duration of the sinus P wave, as measured on the surface
electrocardiogram (ECG) or on the signal-averaged ECG,
which is known to be related to the degree of atrial fibrosis,
is correlated with the risk of postoperative AF (8).
Two modes of treatment, either alone or in combination,
have been proposed to prevent that complication. Pharma-
cologic treatment was used first; its limitations are now well
known. Electrical treatment by overdrive atrial pacing with
sutured epicardial leads has recently been introduced and is
currently being evaluated.
Drug treatment relies mainly on beta-blockers, whose
effectiveness is significantly greater than that of verapamil
and digitalis (1,9), whether they are used preoperatively (in
which case their administration must not be suspended) or
immediately at the start of CABG (administered intrave-
nously). In addition, they permit close control of the
ventricular rate in the event of arrhythmia recurrence (9).
Likewise, d-l sotalol appears to effectively prevent postop-
erative AF with relative innocuousness, particularly in high
risk patients (10,11). A preoperative loading dose of oral
amiodarone, continued postoperatively, produced variable
results. Daoud et al. (12) noted a reduced incidence of
postoperative AF and of its morbidity, resulting in a
significantly shorter hospital stay and proportional cost
reduction (12). In contrast, Redle et al. (13) were not able to
demonstrate any additional benefit of the amiodarone/beta-
blocker association.
Preventive atrial pacing. Different electrophysiologic
mechanisms may explain the antiarrhythmic effect of atrial
pacing (14): 1) Rate control prevents the arrhythmogenic
consequences of bradycardia, irregular heart rate and dis-
persion of refractoriness. This effect may be of special
importance to treat arrhythmias that are directly related to
bradycardia. 2) Overdrive suppression of atrial premature
beats, especially through suppression of automatic foci, may
contribute to AF prevention. It has been known for many
years that atrial and ventricular excitability dispersion or
recovery, as a function of time, is linked to heart rate, and
that the incidence of ectopic beats is itself a function of the
basic rate, at least in the ventricle. It has been clearly
demonstrated that overdrive pacing, either permanent or
dynamic, with the induction of minimal-increment atrial
overdrive pacing after every atrial premature complex, sig-
nificantly reduces the incidence of atrial premature beats.
However, the exact role of atrial extrasystole in arrhythmia
initiation is still a matter of debate. There is still no clear
evidence that extrasystole suppression may significantly
contribute to AF prevention. 3) There is suppression of
compensatory pauses. The deleterious consequences of the
so-called “long–short cycle” or “short–long–short cycle”
phenomenon are known to promote life-threatening ven-
tricular tachyarrhythmia. The same has not clearly been
shown to occur at the atrial level, except in the special case
of vagally mediated atrial tachyarrhythmia. Theoretically,
the electrophysiologic consequences of this phenomenon
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can be prevented by rate-smoothing algorithms, although
the effectiveness of such techniques in preventing arrhyth-
mia is not known. 4) Multisite atrial pacing may contribute
to preventing arrhythmias by different mechanisms. By
correcting asynchrony and the nonuniform activation result-
ing from organic or functional conduction blocks, multisite
pacing may contribute to preventing the occurrence of
macroreentry. Multisite pacing may also work by increasing
the coupling interval of the premature beat in the abnormal
substrate. This can be achieved by preexciting the reentry
area or by selecting one or more pacing sites antidromic to
the premature beat activation. 5) Finally, a number of
experimental reports and the study by Wijffels et al. (15), in
particular, suggest that any treatment that effectively pre-
vents or at least significantly decreases the rate of arrhythmia
recurrence participates in a remodeling process of the
electrophysiologic substrate, which subsequently enhances
the preventive effect of the original treatment. This hypoth-
esis can be applied to cardiac pacing and to other therapeutic
approaches.
So far, the clinical implications of the preventive atrial
pacing concept has been investigated only in severe cases or
emergency situations. Atrial fibrillation after cardiac surgery
was the first emergency situation where the concept could
be evaluated. The results from three recently published (2,3)
or soon-to-be-published (4) controlled studies are consis-
tent with a preventive effect of continuous atrial pacing,
especially when associated with beta-blocker administra-
tion. In Gerstenfeld’s study (2), 61 patients were random-
ized into three groups: one control group without atrial
pacing and two groups subjected to single-site, right atrial or
biatrial overdrive pacing during the first three postoperative
days. Although the incidence of AF episodes in the two
paced groups (33%) was the same as that in the control
group, the authors noted that the frequency of AF in
patients treated with beta-blockers was significantly lower in
the paced groups than in the control group. This cumulative
effect of atrial pacing and drug treatment is classically
observed in permanent pacing and is used to prevent
paroxysmal or persistent AF in chronic forms (16–18).
The results from the study by Greenberg et al. (3),
reported in this issue, were more conclusive. One hundred
and fifty-four patients were randomized into four groups:
one control group with no atrial pacing and three groups
treated with permanent pacing over the first four days after
CABG. One group had pacing exclusively in the right
atrium, another group in the left atrium and the third in
both atria. The proportion of documented AF episodes was
only 17% in the paced groups versus 37% in the control
group (p , 0.005). In that series, the proportion of patients
taking beta-blockers was the same in all groups (i.e., 60% on
average [range 53% to 67%] before CABG and 87% [range
78% to 96%] postoperatively); the mean administration time
interval between CABG and the first dose was 19 6 12 h.
Blommaert et al. (4) also tested the effectiveness of right
atrial pacing, but they used a special permanent overdrive
pacing algorithm to ensure effective atrial capture in .90%
of heart cycles. Ninety-six patients were randomized in two
groups on the second postoperative day: one control group
without pacing and one group with continuous atrial pacing
for 24 h. Effectiveness was assessed by Holter monitor
recordings. The incidence of documented AF episodes was
significantly lower in the paced group (10%) than in the
control group (27%) (p 5 0.036). In contrast, the duration
of AF episodes did not differ significantly between the two
groups. In this study, the proportion of patients who were
prescribed beta-blockers was the same in both groups.
The results from these three studies appeared to confirm
a preventive effect of atrial pacing, either alone or in
combination with beta-blockers, especially when using a
specific dynamic overdrive algorithm whose usefulness in
ensuring permanent atrial capture is obvious in emergency
situations where spontaneous heart rate is often high and
very erratic.
The role of pacing site. The other issue which Gerstenfeld
et al. (2) and Greenberg et al. (3) tried to tackle was whether
the probable positive effects of correcting temporal disper-
sion by overdrive pacing could add to those of spatial
resynchronization by pacing at alternative atrial sites (left
atrium) or, even better, simultaneous pacing of both atria
(biatrial pacing). The results from these two studies were
consistent and apparently not in favor of alternative sites or
biatrial pacing. In the study by Gerstenfeld et al. (2), the
incidence of documented AF episodes after three days was
29% with single-site right atrial pacing and 37% with
biatrial pacing (p 5 NS). In the study by Greenberg et al.
(3), the incidence was 8% with single-site right atrial pacing,
20% with single-site left atrial pacing and 26% with biatrial
pacing (p 5 NS). These results, however, should be inter-
preted with caution because of the technical difficulties of
ensuring effective and durable pacing of the left atrium, and
foremost of both atria, whereas single-site, right atrial
pacing could be maintained throughout the study in all
patients. The technical difficulties raised by temporary left
atrial pacing were clearly illustrated by the clinical experi-
ment described by Kur et al. (17). The aim of that controlled
study was to compare the effects of biatrial overdrive pacing
in the AAI mode at a rate of 10 beats/min above the
intrinsic atrial rate with those of standard drug treatment on
the incidence of acute AF after cardiac surgery. That study,
initially designed to include 200 patients, was prematurely
stopped because of an apparent proarrhythmic effect of
biatrial pacing. Five of 12 patients in the biatrial pacing
group had AF episodes, as compared with only two of nine
in the control group. Analyzing the pacing data should
reveal the occurrence of major technical problems resulting
in ineffectiveness of left atrial pacing in 9 of the 12 patients
treated with biatrial pacing: early loss of left atrial detection
in six patients, phrenic stimulation necessitating that pacing
be stopped in two patients and displacement of the left atrial
lead, thus inducing ventricular stimulation, in one patient.
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Such close monitoring of the effectiveness of left atrial
pacing apparently was not applied to the series reported by
Gerstenfeld et al. (2) and Greenberg et al. (3).
These technical problems were apparently resolved in two
other controlled studies recently presented (5,6) but not yet
published. In Fan et al.’s study (5), involving 105 patients,
biatrial pacing proved significantly more effective (p , 0.05)
than single-site left atrial pacing (AF incidence of 12% vs.
28%) and single-site right atrial pacing (39%). Levy et al.’s
study (6), involving 121 patients, only compared biatrial
pacing with no pacing at all, but reported a marked decrease
in the incidence of AF episodes (14% vs. 39%; p 5 0.002).
Further studies are therefore necessary to reach a conclu-
sion. These studies should scrutinize the technical condi-
tions of pacing and ensure that atrial capture is effective and
durable on the various sites tested and that spontaneous
atrial activity is properly sensed.
The possible benefit of multisite atrial pacing, in com-
parison with standard right atrial pacing, in preventing acute
AF after cardiac surgery, remains to be demonstrated. The
same applies to the prevention of recurrent and drug-
refractory AF in chronic situations. Two different technical
methods have been described for that indication: 1) biatrial
synchronous pacing was described by our group in the early
1990s (16). With that technique, both atria are simulta-
neously paced with two leads, one in the right atrium close
to the sinus node, and the other one, specifically designed
(18), in the median or distal part of the coronary sinus, so as
to selectively detect and pace the left atrium. Both atrial
leads are connected to the atrial port of a DDD (R)
pacemaker through a Y bifurcated adapter. A special “atrial
resynchronization” algorithm is loaded into the RAM
memory of the device, which triggers instantaneous atrial
synchronous pacing after every atrial event is sensed, either
sinus beat or right or left atrial extrasystole. This AAT-like
pacing mode results in permanent atrial resynchronization.
2) The dual-site atrial pacing technique was introduced by
Saksena et al. in 1996 (16). In that technique, the alternative
pacing site is the low posterior right atrium, close to the
coronary sinus ostium, which is known to be a key area for
arrhythmogenesis in patients with AF. The pacing tech-
nique proposed here consists of using a standard DDD (R)
pacemaker with no specific algorithm. Both atrial leads—
the high right atrium and coronary sinus ostium—are
connected to the atrial port of the unit through a Y
bifurcarted adapter. In that technique, the two atrial pacing
sites are simultaneously activated only during the paced
atrial cycles. There is no pacing at any site on the sensed
atrial cycles, either sinus beats or atrial extrasystoles. To
compensate for this technical limitation, the investigators
tried to permanently overdrive the intrinsic atrial rate by
programming fast baseline pacing rates and sensor-driven
pacing and by giving cardiodepressor drugs to reduce the
intrinsic atrial rate.
In fact, it appears that when both sites have been
effectively captured, biatrial pacing and dual-site right atrial
pacing have quasi-identical electrophysiologic effects
(19,20), with significantly reduced global activation time
(P-wave duration) and homogenized local activation times
at the crista terminalis, the His bundle area and the coronary
sinus ostium region, as compared with spontaneous sinus
rhythm and single site-atrial pacing at different pacing sites
(high right atrium, coronary sinus ostium and distal coro-
nary sinus). This indicates that the possible differences in
the clinical effectiveness of the two methods of multisite
atrial pacing are due to the specific characteristics of the
pacing modes used (triggered mode with permanent atrial
resynchronization in biatrial synchronous pacing and over-
drive inhibited mode in dual-site right atrial pacing).
The clinical effects of biatrial synchronous pacing were
primarily assessed in patients with ECG evidence of intra-
atrial conduction delay. The results of a pilot experiment
study using the most advanced technology in “triple-
chamber” pacemakers (“atrial resynchronization” algorithm;
sophisticated Holter functions including intracardiac ECG
storage to provide precise counting and diagnosis of ar-
rhythmia episodes) have recently been reported (21).
Eighty-six patients, mean age 66 years, were prospectively
included. Inclusion criteria were 1) a long history, on
average 5 6 4 years, of recurrent and persistent atrial
tachyarrhythmia with at least two documented episodes in
the preceding six months; 2) failure of drug treatment with
at least 2.7 6 1.8 antiarrhythmic drugs, including amioda-
rone; 3) intra-atrial conduction delay as demonstrated by a
sinus P-wave duration3 of $120 ms and an interatrial
conduction time3 of $100 ms. After pacemaker implanta-
tion the patients were followed up for a mean duration of 33
months, ranging from 6 to 109 months. Atrial resynchro-
nization was demonstrated by a highly significant decrease
in P-wave duration from 187 6 29 ms before implantation
to 106 6 14 ms during biatrial pacing (p , 0.0001). At the
end of follow-up, 55 patients (64%) were still in stable sinus
rhythm, including 28 patients with no documented recur-
rence. The other 27 patients had one or more recurrences in
the paroxysmal or persistent form, or both. In this subgroup
of responder patients, the mean number of drugs was
significantly lower at the end of follow-up than before
implantation (1.4 6 0.6 vs. 1.7 6 0.5; p 5 0.01). The
remaining 31 patients developed chronic AF after a mean
follow-up time of 26 months.
In view of these encouraging results, the investigators
undertook a prospective, randomized, crossover, multicen-
tric study in an attempt to definitively validate the atrial
resynchronization concept. The Synchronous Biatrial Pac-
ing (SYNBIAPACE) study consisted of an intrapatient
comparison of three different pacing modes according to a
dual crossover design over periods of three months: 1)
“inhibited” or no atrial pacing; 2) standard DDD pacing (70
beats/min) at a single high right atrial site; and 3) biatrial
synchronous pacing (DDTA, 70 beats/min). The primary
end point was the time of the first arrhythmia recurrence, as
documented by the Holter functions of the pacemaker,
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including intracardiac ECG storage. Forty-three patients
with no conventional indication for permanent pacing
(mean age 64 years) completed the whole protocol. The
mean P-wave duration before pacemaker implantation was
148 6 31 ms. Preliminary results (22) did not reveal any
statistically significant difference between the three pacing
modes in both the time to first recurrence (62 6 24 days
with DDTA; 37 6 22 days with standard DDD; 39 6 22
days with no atrial pacing; p 5 NS) and the total time spent
in arrhythmia. Despite a trend in favor of biatrial synchro-
nous pacing, these results did not warrant validation of atrial
resynchronization as a sole means to prevent drug-refractory
arrhythmia in patients with intra-atrial conduction delay.
Further studies involving a larger number of patients and
integrating the combined effects of biatrial pacing and an
algorithm of dynamic overdrive pacing will be needed to
determine the true clinical impact of the technique.
Clinical experience with dual-site right atrial pacing is
still limited. Delfaut et al. (18) have recently reported the
long-term results (28 6 11 months) obtained in a series of
30 patients with 1) a long history of symptomatic recurrent
and drug-refractory atrial tachyarrhythmias (i.e., atrial fi-
brillation or atrial flutter, or both); and 2) a conventional
indication for permanent cardiac pacing, principally sinus
node dysfunction or drug-induced bradycardia. The study
protocol consisted of an initial prospective but nonrandom-
ized, sequential crossover comparison of dual-site pacing
with single-site right atrial pacing during three- to six-
month periods. After completing the crossover phase, the
patients were definitively reprogrammed in the dual-site
pacing mode. Evaluation was principally based on the
recurrence rate of symptomatic AF. In comparison with the
three-month period preceding implantation, both atrial
pacing modes significantly increased the proportion of
patients free from symptomatic recurrences (0% with no
pacing vs. 62% with single-site pacing vs. 89% with dual-
site pacing; p , 0.0001) and the arrhythmia-free interval
(9 6 10 days with no pacing vs. 143 6 10 days with
single-site pacing vs. 195 6 96 days with dual-site pacing;
p , 0.0001). Comparing the two atrial pacing modes
revealed significantly greater improvement of the
arrhythmia-free interval with dual-site pacing (p , 0.005).
In the long-term study, 14 patients did not develop a
recurrent episode of symptomatic AF; 11 patients had at
least one recurrence but remained atrially paced; and five
patients developed chronic AF. The total percentage of
patients free from symptomatic AF was 78% at one year and
56% at three years. In the patients who remained atrially
paced at the end of follow-up, the mean number of
antiarrhythmic drugs per patient was not significantly re-
duced, as compared with the period before implantation. In
summary, these preliminary data 1) show that combined
overdrive atrial pacing and antiarrhythmic drug treatment
markedly reduce AF recurrences in patients with a conven-
tional indication for permanent cardiac pacing, and 2) provide
some arguments in favor of a complementary preventive effect
of dual-site atrial pacing as compared with single-site pacing.
However, these results have to be confirmed by prospective,
multicenter, randomized studies. The design and implemen-
tation of dual-site Atrial Pacing to Prevent Atrial Fibrillation
(DAPPAF) trial is now ongoing in the U.S. (23).
In fact, the various modes of multisite pacing are not the
only technical approach to correcting the temporal and
spatial dispersion of refractoriness and conduction which
characterizes a number of patients prone to develop AF in
acute or chronic situations. Spencer et al. (24) recently
showed that pacing in the interatrial septum at its anterior
and superior region, close to Bachman’s bundle, resulted in
a symmetric activation of both atria. This new concept was
assessed in a prospective, randomized study (25) aimed at
comparing the long-term effects of two different modes of
atrial pacing in two parallel groups: conventional high right
atrial pacing, used as the reference mode, and Bachman’s
bundle (BB) pacing. Inclusion criteria were standard indi-
cation of pacing and a history of paroxysmal AF. The BB
pacing significantly reduced the paced P-wave duration as
compared to HRA pacing (123 6 18 vs. 160 6 28 ms; p ,
0.05). More interestingly, the rate of progression toward
chronic AF was significantly lower at 12-month follow-up
with BB pacing than with HRA pacing (21% vs. 41%; p 5
0.004).
In conclusion, these recent data indicate that atrial pacing
may play a significant role in the prevention of drug-
refractory forms of AF in chronic situations and certain
acute forms associated with significant morbidity and over-
cost, as in postoperative AF after cardiac surgery. In that
specific case, the combination of drugs, mainly beta-
blockers, with permanent atrial pacing, making the most of
potent algorithms of dynamic overdrive pacing, appears to
deserve recommendation and could be immediately in-
cluded in routine practice in postoperative intensive care
units. The interest of using pacing sites other than the
classic high right atrium, or even to combine them (biatrial
pacing), remains to be proven. This applies equally to
temporary pacing as a prevention of postoperative AF and to
permanent pacing as a prevention of drug-refractory forms
of paroxysmal or persistent AF.
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